Related Experiment Video
Updated: Jul 10, 2026
Renal Subcapsular Transplantation of 2'-Deoxyguanosine-Treated Murine Embryonic Thymus in Nude Mice
Published on: July 19, 2019
Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled
Eric P Cohen1, Amy A Irving, William R Drobyski
1Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA. ecohen@mcw.edu
Purpose:
To test whether the angiotensin-converting enzyme inhibitor captopril was effective in mitigating chronic renal failure after hematopoietic stem cell transplantation (HSCT).
Methods And Materials:
A total of 55 subjects undergoing total body irradiation (TBI)-HSCT were enrolled in this randomized controlled trial. Captopril or identical placebo was started at engraftment and continued as tolerated until 1 year after HSCT.
Results:
The baseline serum creatinine and calculated glomerular filtration rate (GFR) did not differ between groups. The 1-year serum creatinine level was lower and the GFR higher in the captopril compared with the placebo group (p = 0.07 for GFR). Patient survival was higher in the captopril compared with the placebo group, but this was also not statistically significant (p = 0.09). In study subjects who received the study drug for more than 2 months, the 1-year calculated GFRs were 92 mL/min and 80 mL/min, for the captopril and placebo groups, respectively (p = 0.1). There was no adverse effect on hematologic outcome.
Conclusions:
There is a trend in favor of captopril in mitigation of chronic renal failure after radiation-based HSCT.
Related Concept Videos
01:30Continuous Renal Replacement Therapy
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:11Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:28Kidney Transplant I: Introduction
01:30Heart Failure V: Medical Management
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention